Kevin Slawin

Chairman and CEO

2023 - Current

“Powered by Advanced and Clinically Tested Bioprinting Technologies” Our lead product is 3DMatrix™, a 3D-printed monofilament bioresorbable surgical mesh has received FDA 510(k) clearance.

Founder, CEO and Chairman

2021

Applying high throughput DNA encoded library (DEL) drug screening technologies in novel ways to deliver therapeutics that address the most difficult problems in clinical medicine

Founder CEO and Chairman

2019

Using advanced, proprietary technologies to develop novel therapeutics targeting the fundamental mechanisms of aging. Its lead programs utilize proprietary, state-of-the-art biotechnology platforms to restore the youthful balance of aged or “senescent” and young cells in the skin, targeting the senescent cells for elimination. This provides a “reboot” of one’s genetic program to turn the clock on one’s skin back to its youthful exuberance.

Founder and Managing Partner

2018

Identifying potentially disruptive biopharmaceutical companies within a sea of less compelling opportunities

Chairman of the Board

2022

Conquering the Last Frontier in Patient Monitoring. FIZE® Medical offers the first platform technology to remotely monitor and manage patients with an indwelling Foley catheter, providing unprecedented safety to both patients and their caregivers.

Board Member

2020 - 2022

Founder and Chairman

2021

Physicians, founders, executives and investors working to expand the entrepreneurial healthcare ecosystem in Miami

Chairman of the Board

2021

Building a Best-in-class Urologic Oncology Company. Developing technologies to better visualize and treat urologic cancers through minimally invasive procedures in the physicians’ office

Founding Board Member

2021

Enabling promising early-stage life science companies to develop the next generation of innovative therapies to improve the lives of patients. We want to do this by offering them Contract Research Organization (CRO) Services, newly renovated wet-lab space, process and analytical development support, short-term financing, and third-party due diligence validation, among other services.

Board Member

2020

Co-Founder, Managing Member and CMO

2020